2012 US Preventive Services Task Forc... - Advanced Prostate...

Advanced Prostate Cancer

21,371 members26,725 posts

2012 US Preventive Services Task Force recommendation.

pjoshea13 profile image
3 Replies

New study below.

"We identified all prostate biopsies performed by a large urology group practice ..."

"A total of 4,178 biopsies were identified - 2,513 in 2011 and 1,665 in 2014. The percentage of positive biopsies was 27% in 2011 versus 34% in 2014 ..."

"The percentage of patients with positive biopsies having Gleason scores 8-10 more than doubled in 2014."

Golly! That was unexpected.

-Patrick

ncbi.nlm.nih.gov/pubmed/291...

Investig Clin Urol. 2017 Nov;58(6):423-428. doi: 10.4111/icu.2017.58.6.423. Epub 2017 Nov 2.

US Preventive Services Task Force prostate-specific antigen screening guidelines result in higher Gleason score diagnoses.

Gejerman G1, Ciccone P1, Goldstein M1, Lanteri V1, Schlecker B1, Sanzone J1, Esposito M1, Rome S1, Ciccone M1, Margolis E1, Simon R1, Guo Y1, Pentakota SR2, Sadhegi-Nejad H1.

Author information

1

New Jersey Urology, Hackensack University Medical Center, Hackensack, NJ, USA.

2

Division of Urology, Rutgers New Jersey Medical School, Bloomfield, NJ, USA.

Abstract

PURPOSE:

To evaluate the impact that the 2012 US Preventive Services Task Force (USPSTF) prostate-specific antigen (PSA) screening guidelines have had on the diagnosis of prostate cancer, we compared the incidence and distribution of new cases diagnosed in 2011-before the USPSTF PSA screening recommendations versus 2014 at which time the guidelines were widely adopted.

MATERIALS AND METHODS:

We identified all prostate biopsies performed by a large urology group practice utilizing a centralized pathology lab. We examined total biopsies performed, percentage of positive biopsies, and for those with positive biopsies examined for differences in patient age, PSA, and Gleason score.

RESULTS:

A total of 4,178 biopsies were identified - 2,513 in 2011 and 1,665 in 2014. The percentage of positive biopsies was 27% in 2011 versus 34% in 2014 (p<0.0001). Among patients with positive biopsies, we found statistically significant differences between the 2 cohorts in the median ages and Gleason scores. Patients were about 1 year younger in 2014 compared to 2011 (t-test; p=0.043). High Gleason scores (8-10) were diagnosed in 19% of the 2014 positive biopsies versus 9% in the 2011 positive biopsies (chi square; p<0.0001).

CONCLUSIONS:

After the widespread implementation of the 2011 USPTF PSA screening guidelines, 34% fewer biopsies were performed with a 29% increase in positive biopsy rates. We found a significantly higher incidence of high grade disease in 2014 compared with 2011. The percentage of patients with positive biopsies having Gleason scores 8-10 more than doubled in 2014. The higher incidence of these more aggressive cancers must be part of the discussion regarding PSA screening.

KEYWORDS:

Diagnosis; Gleason score; Prostate neoplasms

PMID: 29124241 PMCID: PMC5671961 DOI: 10.4111/icu.2017.58.6.423

Written by
pjoshea13 profile image
pjoshea13
To view profiles and participate in discussions please or .
Read more about...
3 Replies
cesanon profile image
cesanon

hmmm so reduced PSA testing is causing a greater percentage of biopsies to generate more severe positive results.

Do they talk at all about an increase in the use of non-invasive diagnostic procedures such as all the new forms of imaging?

pjoshea13 profile image
pjoshea13

The PCa "Industry", which profits from more biopsies & more detection has failed to respond to the USPSTF attack. The message in the media & in one's doctor's office has been that screening can (or even should) be skipped.

The rational response would be to use other markers, in addition to PSA, to cut down on biopsies, & Gleason 6 detection, and to get the message into the media that the USPDTF got it wrong but did have valid concerns that have since been addressed.

Instead, we have heard a lot of mumbling, & nothing positive being done to prevent excess Gleason 8-10 cases. Where is the concern for those men?

-Patrick

Neal-Snyder profile image
Neal-Snyder in reply to pjoshea13

Yeah, where was the concern from the urologists & oncologists (or even the task force)? It wasn't very hard to figure out what was going to happen, given that all of us members of the "prostate cancer community" could see that more guys were going to get diagnosed after they had more serious PCa. And few of us have an ounce of medical school. Many of us were even activists on the issue. At least WE had the concern. It kinda looks like the docs were uncaring, don't it?

You may also like...

US doctors forced to ration as cancer drug shortages hit nationwide

791190 (1) To what extent is this affecting prostate cancer treatment drugs? (2) To what extent...

Unsure of best option in early prostate cancer diagnosis.

Acinar adenocarcinoma, Gleason score 3+4 = 7, grade group 2, 5/15 mm, 33% Percentage of pattern 4...

What category of Intermediate Risk Am I?

Predominant Gleason grade 3 (i.e., Gleason score 3+4 or 3+3), and - Percentage of positive biopsy...

Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Detected via PSMA pet scan

was not affected by prostate-specific antigen (PSA) at diagnosis, Gleason score, time from diagnosis

PSA Nadir After RT+ADT for Prostate Cancer Predicts Outcomes

rates for patients with a PSA nadir of 0.1 ng/mL or higher were 14%, 15%, and 14% for the patients...